摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(3S,3aR,6R,6aR)-6-(4-methylbenzoyl)oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl] 4-methylbenzoate | 437711-61-0

中文名称
——
中文别名
——
英文名称
[(3S,3aR,6R,6aR)-6-(4-methylbenzoyl)oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl] 4-methylbenzoate
英文别名
——
[(3S,3aR,6R,6aR)-6-(4-methylbenzoyl)oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl] 4-methylbenzoate化学式
CAS
437711-61-0
化学式
C22H22O6
mdl
——
分子量
382.413
InChiKey
SHZLJDLUCHZAEU-IYWMVGAKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    28
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    71.1
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    Structural Analysis of Chiral Dopants in Nematic Systems by Example of Ether-Ester-Substituted 1,4:3,6-Dianhydrohexitols
    摘要:
    Series of ether-ester-substituted 1,4:3,6-dianhydrohexitols were synthesized and studied as chiral dopants to nematics as compositions with 4 '-pentyl-4-cyanobiphenyl. The most helical twisting power was found for bis-esters. Lesser values were found for mixed ether-esters with certain configuration. Other ethers and ether-esters revealed noticeably smaller values. Supramolecular peculiarities of such systems and their role in helical twisting are discussed.
    DOI:
    10.1080/15421406.2013.833476
点击查看最新优质反应信息

文献信息

  • Photochromic Indeno-Fused Ring Pyran Compounds
    申请人:Transitions Optical, Inc.
    公开号:US20150141661A1
    公开(公告)日:2015-05-21
    The present invention relates to photochromic indeno-fused ring pyran compounds represented by the following Formula (I-A): The present invention also relates to photochromic dichroic compounds, such as represented by Formula (I-A), in which (i) Z 2 is a group N—R 13 in which R 13 is a group L, and (ii) optionally at least one R 1 independently for each n is selected from a group L, in which the group L independently in each case is a lengthening group that provides the photochromic compound with dichroic properties, in accordance with some embodiments. The present invention also relates to photochromic articles, such as photochromic ophthalmic articles, that include one or more photochromic compounds according to the present invention, such as represented by Formula (I-A).
    本发明涉及由以下式(I-A)表示的光致变色吲哚融合环喃化合物。本发明还涉及光致二向色化合物,例如由式(I-A)表示,其中(i)Z2是一个N—R13基团,其中R13是一个L基团,以及(ii)对于每个n,可选地至少选择一个R1,每种情况下独立选择自L基团,其中每种情况下L基团是一个提供光致化合物二向色性能的延伸基团,符合某些实施例。本发明还涉及光致物品,例如光致眼科物品,包括根据本发明的一个或多个光致化合物,例如由式(I-A)表示。
  • Method Of Preparing Fused Ring Indeno Compounds
    申请人:Transitions Optical, Inc.
    公开号:US20160060205A1
    公开(公告)日:2016-03-03
    The present invention relates to methods of preparing fused ring indeno compounds that involves reacting together a dienophile and a lactone compound, in the presence of a catalyst, and a carboxylic acid anhydride. With some embodiments, the fused ring indeno compound is represented by the following Formula (I-A), the dienophile is represented by the following Formula (II-A), and the lactone compound is represented by the following Formula (III-A):
    本发明涉及制备融合环吲哚化合物的方法,包括在催化剂羧酸酐存在下,将二丙烃和内化合物反应。在某些实施例中,所述融合环吲哚化合物由以下式(I-A)表示,所述二丙烃由以下式(II-A)表示,所述内化合物由以下式(III-A)表示:
  • PHOTOCHROMIC INDENO-FUSED RING PYRAN COMPOUNDS
    申请人:Transitions Optical, Inc.
    公开号:EP3071576B1
    公开(公告)日:2021-08-18
  • PHOTOCHROMIC THIENOCHROMENE COMPOUNDS
    申请人:Transitions Optical, Inc.
    公开号:EP3268375B1
    公开(公告)日:2022-06-15
  • US9029565B1
    申请人:——
    公开号:US9029565B1
    公开(公告)日:2015-05-12
查看更多

同类化合物

顺式-2,3,3a,6a-四氢呋喃[2,3-b]呋喃 莱克酮 索尼地平 硝酸异山梨酯 溴化二氢6-(联苯基-4-基)-3-氯-12,13-二甲氧基-9,10--7H-异奎并[2,1-d][1,4]苯并二氮卓-8-正离子 星形曲霉毒素 抗坏血酸原 A 异山梨醇二甲基醚 异山梨醇13C65-单酸酯 异山梨醇 失水甘露醇单油酸酯 失水甘露醇单油酸酯 大青素 地瑞那韦中间体1 四氢呋喃[2,3-B]呋喃-2(6AH)-酮 四氢-6a-甲基-呋喃并[2,3-b]呋喃-2(3H)-酮 四氢-6-硫代-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3-酮 去甲斑蝥素 单硝酸异山梨酯杂质C 单-9-十八烯酸1,4:3,6-双脱水-D-甘露醇酯 华北白前甙元B 六氢呋喃并[2,3-b]呋喃-3-醇 六氢呋喃并[2,3-b]呋喃 六氢-呋喃并[2,3-b]呋喃-3-醇 克罗拉滨杂质7 二氯萘 二氢-1,4-二甲基-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3,6(4H)-二酮 二氢-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3,6(4H)-二酮 二氢-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3,6(4H)-二硫酮 乙酸异山梨醇酯 丙氨酸,N-(5-氯-2-羟基苯甲酰)- N-乙酰基-L-丙氨酰-L-酪氨酸 L-葡糖酸-3,6-内酯 D-葡糖醛酸-γ-内酯丙酮化合物 D-甘露呋喃糖醛酸 gamma-内酯 BISTHFHNS衍生物3 7H,10H-呋喃并[2,3,4-cd]萘并[2,1-e]异苯并呋喃-7-酮,十四氢-10-羟基-1,1,4a-三甲基-,(4aS,4bR,6aR,8aR,10R,10aS,10bR,12aS)-(9CI) 7-氧杂二环[2.2.1]庚-5-烯-2,3-二羧酸酐 6H,9H-苯并[e]呋喃并[2,3,4-cd]异苯并呋喃-6-酮,2,4,4a,5,7,8,10a,10b-八氢-5,5-二甲基-,(4aR,8aR,10aR,10bS)-(9CI) 6-[(1E,3E,5E)-6-[(1R,2R,3R,5R,7R,8R)-7-乙基-2,8-二羟基-1,8-二甲基L-4,6-二氧杂双环[3.3.0]辛-3-基]己-1,3,5-三烯基]-4-甲氧基-5-甲基-吡喃-2-酮 5-单硝酸异山梨酯 5-乙酸异山梨酯 5-乙酸异山梨酯 5-[(4,6-二氯-1,3,5-三嗪-2-基)氨基]-4-羟基-3-[(4-磺酸根-1-萘基)偶氮]萘-2,7-二磺化三钠 5,6-二溴-7-氧杂双环[2.2.1]庚烷-2,3-二甲酸酐 5,5-二甲基-4,8-二氧杂三环[4.2.1.03,7]壬-2-基丙烯酸酯 4-硝基苯并[pqr]四苯-1-醇 4,10-二氧杂三环[5.2.1.0(2,6)]癸-8-烯-3-酮 4,10-二氧杂三环[5.2.1.0(2,6)]癸-8-烯-3,5-二酮 3-脱氧-14,15-二氢-15-羟基-莸酯素醇